Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

For Speedy Release: December 23, 2021 Español Nowadays, the U.S. Foodstuff and Drug Administration issued an unexpected emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of gentle-to-moderate coronavirus disease (COVID-19) in grown ups with positive outcomes of direct SARS-CoV-two viral testing, and who are at superior risk for […]

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19

For Immediate Release: December 22, 2021 Español Today, the U.S. Foods and Drug Administration issued an crisis use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the cure of mild-to-average coronavirus condition (COVID-19) in adults and pediatric individuals (twelve several years of age […]

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

For Instant Release: August twelve, 2021 Español These days, the U.S. Food and Drug Administration amended the crisis use authorizations (EUAs) for each the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an added dose in specified immunocompromised individuals, exclusively, stable organ transplant recipients […]